• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“这将容易得多”:卫生系统主导的遗传风险告知——综合系统中级联筛查的可行性与可接受性

"It would be so much easier": health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system.

作者信息

Henrikson Nora B, Blasi Paula R, Fullerton Stephanie M, Grafton Jane, Leppig Kathleen A, Jarvik Gail P, Larson Eric B

机构信息

Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.

Department of Bioethics and Humanities, School of Medicine, University of Washington, Seattle, WA, USA.

出版信息

J Community Genet. 2019 Oct;10(4):461-470. doi: 10.1007/s12687-019-00412-z. Epub 2019 Mar 6.

DOI:10.1007/s12687-019-00412-z
PMID:30843145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6754469/
Abstract

Assess the feasibility and acceptability of health system-led genetic risk notification in a US integrated health system. We conducted semi-structured phone interviews with individuals age 40-64 years who had undergone genetic sequencing, but had not yet received their results, assessing attitudes to direct outreach to relatives. During each interview, we collected contact information for adult relatives identified as members of the same system and attempted to identify each relative in administrative data. We conducted 20 interviews. Most participants expressed support for Kaiser Permanente Washington involvement in familial risk notification. Direct outreach to relatives received the most unqualified support; outreach to the relatives' physician or interaction with the relatives' electronic medical record received more tempered support. Support was motivated by the desire to have risk communicated accurately and quickly. The most common caveat was a desire to alert relatives before the health system contacted them. Of 57 named relatives who were members of the same health system, we retrieved a single match for 40 (70.2%) based on name or birthdate. Health system involvement in familial risk notification received support in a sample of patients in a US integrated health system, and identification of relatives is feasible.

摘要

评估美国综合医疗系统中由医疗系统主导的基因风险告知的可行性和可接受性。我们对40至64岁已接受基因测序但尚未收到结果的个体进行了半结构化电话访谈,评估他们对直接联系亲属的态度。在每次访谈中,我们收集了被确定为同一系统成员的成年亲属的联系信息,并试图在行政数据中识别每位亲属。我们进行了20次访谈。大多数参与者表示支持凯撒医疗集团华盛顿分部参与家族风险告知。直接联系亲属得到了最无条件的支持;联系亲属的医生或与亲属的电子病历互动得到的支持则较为有限。支持的动机是希望风险能被准确、迅速地传达。最常见的附加条件是希望在医疗系统联系亲属之前先提醒他们。在57名被提及的属于同一医疗系统的亲属中,我们根据姓名或出生日期成功匹配到了40名(70.2%)。在美国综合医疗系统的患者样本中,医疗系统参与家族风险告知得到了支持,并且识别亲属是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e00/6754469/3040700510b7/12687_2019_412_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e00/6754469/3040700510b7/12687_2019_412_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e00/6754469/3040700510b7/12687_2019_412_Fig1_HTML.jpg

相似文献

1
"It would be so much easier": health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system.“这将容易得多”:卫生系统主导的遗传风险告知——综合系统中级联筛查的可行性与可接受性
J Community Genet. 2019 Oct;10(4):461-470. doi: 10.1007/s12687-019-00412-z. Epub 2019 Mar 6.
2
Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation.卫生系统主导的家族风险通知的可行性、可接受性及有限疗效:一项混合方法评估方案
Pilot Feasibility Stud. 2022 Aug 9;8(1):174. doi: 10.1186/s40814-022-01142-9.
3
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis.替代级联检测方案用于识别和管理家族性高胆固醇血症患者:系统评价、定性研究和成本效益分析。
Health Technol Assess. 2023 Oct;27(16):1-140. doi: 10.3310/CTMD0148.
4
Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention.利用基于网络的家谱、直接面向消费者的祖先遗传学和社交媒体进行遗传性癌症的大家庭外展:ConnectMyVariant干预措施的混合方法过程评估
JMIR Cancer. 2023 Apr 20;9:e43126. doi: 10.2196/43126.
5
"I Didn't Have to Worry about It": Patient and Family Experiences with Health System Involvement in Notifying Relatives of Genetic Test Results.“我不必为此担心”:患者及其家属对健康系统参与通知亲属遗传检测结果的体验。
Public Health Genomics. 2024;27(1):150-160. doi: 10.1159/000541532. Epub 2024 Sep 30.
6
Communicating familial hypercholesterolemia genetic information within families.在家族内部传递家族性高胆固醇血症的遗传信息。
Genet Test Mol Biomarkers. 2009 Jun;13(3):301-6. doi: 10.1089/gtmb.2008.0138.
7
Cascade testing for inherited arrhythmia conditions: Experiences and attitudes of family communication approaches for a Canadian cohort.级联检测遗传性心律失常疾病:加拿大队列的家族沟通方法的经验和态度。
J Genet Couns. 2022 Jun;31(3):815-828. doi: 10.1002/jgc4.1550. Epub 2022 Jan 14.
8
Cascade screening for beta-thalassemia in Pakistan: development, feasibility and acceptability of a decision support intervention for relatives.巴基斯坦β-地中海贫血症的级联筛查:为亲属开发、评估和接受决策支持干预的可行性研究。
Eur J Hum Genet. 2022 Jan;30(1):73-80. doi: 10.1038/s41431-021-00918-6. Epub 2021 Jun 14.
9
Usefulness of mobile apps for communication of genetic test results to at-risk family members in a U.S. integrated health system: a qualitative approach from user-testing.移动应用程序在美国综合医疗系统中向高危家庭成员传达基因检测结果的效用:来自用户测试的定性方法
Health Policy Technol. 2021 Jun;10(2). doi: 10.1016/j.hlpt.2021.100511. Epub 2021 Apr 22.
10
Risk Communication in Families of Children with Familial Hypercholesterolemia: Identifying Motivators and Barriers to Cascade Screening to Improve Diagnosis at a Single Medical Center.家族性高胆固醇血症患儿家庭中的风险沟通:在单一医疗中心识别级联筛查的动机和障碍以改善诊断
J Genet Couns. 2018 Aug 14. doi: 10.1007/s10897-018-0290-0.

引用本文的文献

1
Health System-Led Early Consent and Direct Contact of At-Risk Relatives: Pilot Study Results.卫生系统主导的高危亲属早期同意及直接联系:试点研究结果
Public Health Genomics. 2025;28(1):150-162. doi: 10.1159/000545404. Epub 2025 Apr 3.
2
Health professionals contacting patients' relatives directly about genetic risk (with patient consent): current clinical practice and perspectives.在获得患者同意的情况下,医疗专业人员直接联系患者亲属告知基因风险:当前临床实践与观点。
Eur J Hum Genet. 2025 Apr;33(4):476-484. doi: 10.1038/s41431-024-01730-8. Epub 2024 Dec 19.
3
"I Didn't Have to Worry about It": Patient and Family Experiences with Health System Involvement in Notifying Relatives of Genetic Test Results.

本文引用的文献

1
Reconsidering the duty to warn genetically at-risk relatives.重新考虑向具有遗传风险的亲属发出警告的责任。
Genet Med. 2018 Mar;20(3):285-290. doi: 10.1038/gim.2017.257. Epub 2018 Feb 1.
2
Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience.与基因组医学项目结果反馈相关的伦理考量:eMERGE 网络(第三阶段)经验
J Pers Med. 2018 Jan 3;8(1):2. doi: 10.3390/jpm8010002.
3
Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach.
“我不必为此担心”:患者及其家属对健康系统参与通知亲属遗传检测结果的体验。
Public Health Genomics. 2024;27(1):150-160. doi: 10.1159/000541532. Epub 2024 Sep 30.
4
Investigating genetic counselors' communication with Lynch syndrome patients about cascade testing: Barriers, facilitators, and strategies.调查遗传咨询师与林奇综合征患者就级联检测进行沟通的情况:障碍、促进因素及策略。
J Genet Couns. 2025 Apr;34(2):e1937. doi: 10.1002/jgc4.1937. Epub 2024 Jul 4.
5
Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure.患者告知亲属的认知和实践:一项在医疗辅助风险披露随机试验中的定性研究。
Eur J Hum Genet. 2024 Apr;32(4):448-455. doi: 10.1038/s41431-024-01544-8. Epub 2024 Feb 2.
6
An Examination of the Ethical and Legal Limits in Implementing "Traceback Testing" for Deceased Patients.对实施已故患者“溯源检测”的伦理和法律限制的考察。
J Law Med Ethics. 2022;50(4):818-832. doi: 10.1017/jme.2023.23.
7
Environmental scan of family chart linking for genetic cascade screening in a U.S. integrated health system.美国综合医疗系统中用于遗传级联筛查的家族图谱链接的环境扫描。
Front Genet. 2022 Aug 11;13:886650. doi: 10.3389/fgene.2022.886650. eCollection 2022.
8
Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation.卫生系统主导的家族风险通知的可行性、可接受性及有限疗效:一项混合方法评估方案
Pilot Feasibility Stud. 2022 Aug 9;8(1):174. doi: 10.1186/s40814-022-01142-9.
9
Patient and Family Preferences on Health System-Led Direct Contact for Cascade Screening.患者及家属对卫生系统主导的级联筛查直接接触的偏好。
J Pers Med. 2021 Jun 10;11(6):538. doi: 10.3390/jpm11060538.
10
What improves the likelihood of people receiving genetic test results communicating to their families about genetic risk?哪些因素提高了人们将基因检测结果告知家人的可能性?
Patient Educ Couns. 2021 Apr;104(4):726-731. doi: 10.1016/j.pec.2021.01.001. Epub 2021 Jan 7.
回溯:一个通过基于家庭的外展服务来增加BRCA1和BRCA2突变携带者的识别与遗传咨询的提议框架。
J Clin Oncol. 2017 Jul 10;35(20):2329-2337. doi: 10.1200/JCO.2016.70.3439. Epub 2017 Apr 11.
4
Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals.在基因组医学中探讨家庭层面的隐私保密问题:一项针对医疗保健专业人员的焦点小组研究。
BMJ Open. 2017 Feb 3;7(2):e012443. doi: 10.1136/bmjopen-2016-012443.
5
A Relational Approach to Genetic Counseling for Hereditary Breast and Ovarian Cancer.一种针对遗传性乳腺癌和卵巢癌的遗传咨询关系方法。
J Genet Couns. 2017 Apr;26(2):283-299. doi: 10.1007/s10897-016-0022-2. Epub 2016 Oct 19.
6
The Utility of Template Analysis in Qualitative Psychology Research.模板分析在定性心理学研究中的效用
Qual Res Psychol. 2015 Apr 3;12(2):202-222. doi: 10.1080/14780887.2014.955224. Epub 2014 Sep 2.
7
A Duty To Warn Relatives in Clinical Genetics: Arguably 'Fair just and reasonable' in English Law?临床遗传学中向亲属发出警告的义务:在英国法律中是否可说是“公平、公正且合理”?
Tottels J Prof Neglig. 2016 Jul;32(2):120-136.
8
Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.年轻乳腺癌女性患者癌症基因检测结果家庭沟通中的心理社会和临床因素
J Genet Couns. 2017 Feb;26(1):173-181. doi: 10.1007/s10897-016-9995-0. Epub 2016 Jul 16.
9
The Right Not to Know and the Duty to Tell: The Case of Relatives.不知情权与告知义务:亲属的案例
J Law Med Ethics. 2014 Spring;42(1):38-52. doi: 10.1111/jlme.12117.
10
'Is this knowledge mine and nobody else's? I don't feel that.' Patient views about consent, confidentiality and information-sharing in genetic medicine.“这些知识是我的,别人都没有吗?我不这么觉得。”患者对基因医学中知情同意、保密和信息共享的看法。
J Med Ethics. 2016 Mar;42(3):174-9. doi: 10.1136/medethics-2015-102781. Epub 2016 Jan 7.